Anthera Pharmaceuticals, Inc. (ANTH)
OTCMKTS
· Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
Jan 17, 2025, 4:00 PM EST
Anthera Pharmaceuticals Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
21
Market Cap
26.00
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.79B |
Veradigm | 1.53B |
SS Innovations International | 16.04M |
Elite Pharmaceuticals | 71.17M |
Glass House Brands | 188.29M |
Northwest Biotherapeutics | 1.60M |
BioStem Technologies | 210.49M |
Silence Therapeutics | 21.77M |
Anthera Pharmaceuticals News
- 4 years ago - AM Best Assigns Issue Credit Ratings to Anthem, Inc.'s New Senior Unsecured Notes - Business Wire
- 4 years ago - AM Best Comments on Credit Ratings of Anthem, Inc. and Its Subsidiaries Following MMM Holdings, LLC Acquisition Announcement - Business Wire